2 results match your criteria: "and the Pennington Biomedical Research Center[Affiliation]"
FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial.
Am J Clin Nutr
May 2014
Departments of Nutrition (TH, QQ, FBH, FMS, and LQ) and Epidemiology (FBH), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (YL, FBH, and LQ); and the Pennington Biomedical Research Center of the Louisiana State University System, Baton Rouge, LA (GAB and DAW).
Background: A common obesity-risk variant rs9939609 in the fat mass- and obesity-associated (FTO) gene was recently shown to affect appetite, and the gene is sensitive to the regulation of amino acids.
Objective: We examined the interaction between FTO genotype and protein intake on the long-term changes in appetite in a randomized controlled trial.
Design: We genotyped FTO rs9939609 in 737 overweight adults in the 2-y Preventing Overweight Using Novel Dietary Strategies trial and assessed 4 appetite-related traits including cravings, fullness, hunger, and prospective consumption.
Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study.
Am J Clin Nutr
January 2010
Washington University School of Medicine, St Louis, MO, and the Pennington Biomedical Research Center, Baton Rouge, LA 63108, USA.
Background: Phytosterol supplementation of 2 g/d is recommended by the National Cholesterol Education Program to reduce LDL cholesterol. However, the effects of different intakes of phytosterol on cholesterol metabolism are uncertain.
Objective: We evaluated the effects of 3 phytosterol intakes on whole-body cholesterol metabolism.